HR729-119

In Committee

Teleabortion Prevention Act of 2025

119th Congress Introduced Jan 24, 2025

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

This bill, Teleabortion Prevention Act of 2025, changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Trade, Foreign Policy.

Who Benefits and How

health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.

Who Bears the Burden and How

federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.

Key Provisions

  • Section H7FA632959D7D49B2981D702EE54EA8EE: 1. Short title This Act may be cited as the Teleabortion Prevention Act of 2025.
  • Section HC3700435B8DD4E199BED03FD3602F153: 2. Chemical abortions prohibited without a healthcare provider present Chapter 74 of title 18, United States Code, is amended— in the chapter heading by...
  • Section H0A07454876934861912DA3F477CC1F97: 1532. Chemical abortions prohibited without a healthcare provider physically present Any healthcare provider who, in or affecting interstate or foreign...

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

This bill, Teleabortion Prevention Act of 2025, changes federal law or congressional policy affecting health care providers and patients.

Key Policy Areas

Healthcare, Trade, Foreign Policy

Primary Purpose

This bill, Teleabortion Prevention Act of 2025, changes federal law or congressional policy affecting health care providers and patients.

Policy Domains

Healthcare Trade Foreign Policy

Whole bill

Identified Gains
  • health care providers and patients
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
health care providers and patients: ,
Identified Costs
  • federal implementing agencies
  • health care providers and patients
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
federal implementing agencies: ,
health care providers and patients: ,

Legislative Progress

In Committee
Introduced Committee Passed
Jan 24, 2025

Mr. Harris of North Carolina (for himself, Mr. Clyde, Mr. …

Jan 24, 2025

Referred to the House Committee on the Judiciary.

Jan 24, 2025

Introduced in House

Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Trade Foreign Policy
Actor Mappings
"federal_implementing_agencies"
→ Federal agencies assigned duties by the bill

Key Definitions

Terms defined in this bill

2 terms
"provide," §H0A07454876934861912DA3F477CC1F97

to dispense or prescribe an abortion drug, or to otherwise make an abortion drug available to a patient. The term chemical abortion refers to the use of an abortion drug to— intentionally kill the unborn child of a woman known to be pregnant

"abortion drug" §HC3700435B8DD4E199BED03FD3602F153

any medicine, drug or any other substance, or any combination of drugs, medicines or substances, when it is used— (A)to intentionally kill the unborn child of a woman known to be pregnant

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology